Severity and properties of cardiac damage caused by Streptococcus pneumoniae are strain dependent

PLoS ONE

Volumn 13, Issue 9, 2018, Pages

  Shenoy, Anukul T ^a,c   Beno, Sarah M ^a   Brissac, Terry ^a   Bell, Jeremiah W ^a   Novak, Lea ^b   Orihuela, Carlos J ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE BINDING PROTEIN A; MEMBRANE PROTEIN; PNEUMOLYSIN; TROPONIN I; UNCLASSIFIED DRUG; TROPONIN T;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CARDIAC MUSCLE CELL; CARDIOTOXICITY; CELL DEATH; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART INJURY; HEART TISSUE; HISTOPATHOLOGY; IMMUNOBLOTTING; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SEROTYPE; STAINING; STREPTOCOCCUS PNEUMONIAE; ANIMAL; BLOOD; C57BL MOUSE; CARDIOMYOPATHY; CLASSIFICATION; COMPLICATION; DISEASE MODEL; HUMAN; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PNEUMOCOCCAL INFECTION; SPECIES DIFFERENCE; VIRULENCE;

ANIMALS; BACTEREMIA; BACTERIAL LOAD; CARDIOMYOPATHIES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MICE; MICE, INBRED C57BL; MYOCYTES, CARDIAC; PNEUMOCOCCAL INFECTIONS; SEROGROUP; SPECIES SPECIFICITY; STREPTOCOCCUS PNEUMONIAE; TROPONIN T; VIRULENCE;

EID: 85053358270     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0204032     Document Type: Article

References (40)

1. Shenoy AT, Orihuela CJ. Anatomical site-specific contributions of pneumococcal virulence determinants. Pneumonia. 2016; 8:7. https://doi.org/10.1186/s41479-016-0007-9 PMID: 27635368
2. Butler JC, Schuchat A. Epidemiology of pneumococcal infections in the elderly. Drugs & Aging. 1999; 15: 11-19. https://doi.org/10.2165/00002512-199915001-00002
3. Randle E, Ninis N, Inwald D. Invasive pneumococcal disease. Arch Dis Child Educ Pract Ed. 96: 183-190. https://doi.org/10.1136/adc.2010.191718 PMID: 21555595
4. Tan TQ. Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines. Clin Microbiol Rev. 2012; 25(3): 409-419. https://doi.org/10.1128/CMR.00018-12 PMID: 22763632
5. Morrill HJ, Caffrey AR, Noh E, LaPlante KL. Epidemiology of pneumococcal disease in a national cohort of older adults. Infect Dis Ter. 2014; 3(1): 19-33. https://doi.org/10.1007/s40121-014-0025-y PMID: 25134809
6. Navarro-Torné A, Dias JG, Hruba F, Lopalco PL, Pastore-Celentano L, Amato Gauci AJ, et al. Risk factors for death from invasive pneumococcal disease, Europe, 2010. Emerg Infect Dis. 2015; 21(3): 417-425. https://doi.org/10.3201/eid2103.140634 PMID: 25693604
7. World Health Organization. Estimated Hib and pneumococcal deaths for children under 5 years of age, 2008. World Health Organization. 2008. Available from: http://www.who.int/immunization/monitoring- surveillance/burden/estimates/Pneumo-hib/en/. Cited 14 March 2018.
8. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Streptococcus pneumoniae, 2015. Available from: https://www.cdc.gov/abcs/ reports-findings/survreports/spneu15.html. Cited on 14 March 2018.
9. DeGraff AC, Travell JG, Yager JA. An electrocardiographic study of the heart in lobar pneumonia. J Clin Invest. 1931; 10(3): 633-651. https://doi.org/10.1172/JCI100374 PMID: 16694002
10. Master AM, Romanoff A, Jaffe H. Electrocardiographic changes in pneumonia. Am Heart J. 1931; 6(5): 696-709. https://doi.org/10.1016/S0002-8703(31)90444-4
11. Thomson KJ, Rutstein DD, Tolmach DM, Walker WH. Electrocardiographic studies during and after pneumococcus pneumonia. Am Heart J. 1946; 31(5): 565-579. https://doi.org/10.1016/0002-8703(46) 90003-8
12. Corrales-Medina VF, Musher DM, Wells GA, Chirinos JA, Chen L, Fine MJ. Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation. 2012; 125(6): 773-781. https://doi.org/10.1161/CIRCULATIONAHA. 111.040766 PMID: 22219349
13. Corrales-Medina VF, Taljaard M, Yende S, Kronmal R, Dwivedi G, Newman AB, et al. Intermediate and long-term risk of new-onset heart failure after hospitalization for pneumonia in elderly adults. Am Heart J. 2015; 170(2): 306-312. https://doi.org/10.1016/j.ahj.2015.04.028 PMID: 26299228
14. Musher DM, Rueda AM, Kaka AS, Marapara SM. The association between pneumococcal pneumonia and acute cardiac events. Clin Infect Dis. 2007; 45: 158-165. https://doi.org/10.1086/518849 PMID: 17578773
15. Eurich DT, Marrie TJ, Minhas-Sandhu JK, Majumdar SR. Risk of heart failure after community acquired pneumonia: prospective controlled study with 10 years of follow-up. BMJ. 2017; 356. https://doi.org/10. 1136/bmj.j413 PMID: 28193610
16. Brown AO, Mann B, Gao G, Hankins JS, Humann J, Giardina J, et al. Streptococcus pneumoniae translocates into the myocardium and forms unique microlesions that disrupt cardiac function. PLOS Pathog. 2014; 10(9): e1004383. https://doi.org/10.1371/journal.ppat.1004383 PMID: 25232870
17. Gilley RP, González-Juarbe N, Shenoy AT, Reyes LF, Dube PH, Restrepo MI, et al. Infiltrated macrophages die of pneumolysin-mediated necroptosis following pneumococcal myocardial invasion. Infect Immun. 2016; 84(5): 1457-1469. https://doi.org/10.1128/IAI.00007-16 PMID: 26930705
18. Brissac T, Shenoy AT, Patterson LA, Orihuela CJ. Cell invasion and pyruvate oxidase derived H2O2 are critical for Streptococcus pneumoniae mediated cardiomyocyte killing. Infect Immun. 2017. https://doi. org/10.1128/IAI.00569-17 PMID: 29061707
19. Shenoy AT, Brissac T, Gilley RP, Kumar N, Wang Y, Gonzalez-Juarbe N, et al. Streptococcus pneumoniae in the heart subvert the host response through biofilm-mediated resident macrophage killing. PLOS Pathog. 2017; 13(8): e1006582. https://doi.org/10.1371/journal.ppat.1006582 PMID: 28841717
20. Fillon S, Soulis K, Rajasekaran S, Benedict-Hamilton H, Radin JN, Orihuela CJ, et al. Platelet-activating factor receptor and innate immunity: uptake of gram-positive bacterial cell wall into host cells and cellspecific pathophysiology. J Immunol. 2006; 177(9): 6182-6191. https://doi.org/10.4049/jimmunol.177. 9.6182 PMID: 17056547
21. Alhamdi Y, Neill DR, Abrams ST, Malak HA, Yahya R, Barrett-Jolley R, et al. Circulating pneumolysin is a potent inducer of cardiac injury during pneumococcal infection. PLOS Pathog. 2015 May 14; 11(5): e1004836. https://doi.org/10.1371/journal.ppat.1004836 PMID: 25973949
22. Liu H, Lee SS. Nuclear factor-kB inhibition improves myocardial contractility in rats with cirrhotic cardiomyopathy. Liver Int. 2008; 28(5): 640-8. https://doi.org/10.1111/j.1478-3231.2008.01692
23. Tettelin H, Hollingshead SK. Comparative genomics of Streptococcus pneumoniae: intrastrain diversity and genome plasticity. In: Tuoanen EI, Mitchell T, Morrison DA, Spratt BG (ed), The pneumococcus. Washington DC: ASM Press; 2004. pp. 15-29.
24. Lizcano A, Chin T, Sauer K, Tuomanen EI, Orihuela CJ. Early biofilm formation on microtiter plates is not correlated with the invasive disease potential of Streptococcus pneumoniae. Microb Pathog. 2011; 48(3-4): 124-130. https://doi.org/10.1016/j.micpath.2010.01.002 PMID: 20096771
25. Blanchette-Cain K, Hinojosa CA, Akula Suresh Babu R, Lizcano A, Gonzalez-Juarbe N, Munoz-Almagro C, et al. Streptococcus pneumoniae biofilm formation is strain dependent, multifactorial, and associated with reduced invasiveness and immunoreactivity during colonization. mBio. 2013; 4(5): e00745. https://doi.org/10.1128/mBio.00745-13 PMID: 24129258
26. Blanchette KA, Shenoy AT, Milner J II, Gilley RP, McClure E, Hinojosa CA, et al. Neuamidiase Aexposed galactose promotes Streptococcus pneumoniae biofilm formation during colonization. Infect Immun. 2016; 84(10): 2922-2932. https://doi.org/10.1128/IAI.00277-16 PMID: 27481242
27. Lanie JA, Ng WL, Kazmierczk KM, Andrzejewski TM, Davidsen TM, Wayne KJ, et al. Genome sequence of Avery's virulent serotype 2 strain D39 of Streptococcus pneumoniae and comparison with that of unencapsulated laboratory strain R6. J Bacteriol. 2007; 189(1): 38-51. https://doi.org/10.1128/ JB.01148-06 PMID: 17041037
28. Briles DE, Nahm M, Schoroer K, Davie J, Baker P, Kearney J, et al. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae. J Exp Med. 1981; 153: 694-705. https://doi.org/10.1084/jem.153.3.694 PMID: 7252411
29. Tettelin H, Nelson KE, Paulsen IT, Eisen JA, Read TD, Peterson S, et al. Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science. 2001; 293(5529): 498-506. https://doi.org/ 10.1126/science.1061217 PMID: 11463916
30. Obert C, Sublett J, Kaushal D, Hinojosa E, Barton T, Tuomanen EI, et al. Identification of a candidate Streptococcus pneumoniae core genome and regions of diversity correlated with invasive pneumococcal disease. Infect Immun. 2006; 74(8): 4766-4777. https://doi.org/10.1128/IAI.00316-06 PMID: 16861665
31. Briles DE, Hollingshead SK, Paton JC, Ades EW, Novak L, van Ginkel FW, et al. Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae. J Infect Dis. 2003; 188(3): 339-348. https:// doi.org/10.1086/376571 PMID: 12870114
32. McCullers JA, McAuley JL, Browall S, Iverson AR, Boyd KL, Normark BH. Influenza enhances susceptibility to natural acquisition and disease from Streptococcus pneumoniae in ferrets. J Infect Dis. 2010; 202(8): 1287-1295. https://doi.org/10.1086/656333 PMID: 20822454
33. Romero-Steiner S, Frasch C, Concepcion N, Goldblatt D, Käyhty H, Väkeväinen M, et al. Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae. Clin Diagn Lab Immunol. 2003; 10(6): 1019-1024. https://doi.org/10.1128/CDLI.10.6.1019-1024.2003 PMID: 14607861
34. Brown AO, Millett ERC, Quint JK, Orihuela CJ. Cardiotoxicity during invasive pneumococcal disease. Am J Respir Crit Care Med. 2015; 191(7): 739-745. https://doi.org/10.1164/rccm.201411-1951PP PMID: 25629643
35. Daley JM, Thomay AA, Connolly MD, Reichner JS, Albina JE. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol. 2008; 83(1): 64-70. https://doi.org/10.1189/jlb. 0407247 PMID: 17884993
36. Orihuela CJ, Mahdavi J, Thornton J, Mann B, Wooldridge KG, Abouseada N, et al. Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models. JCI. 2009; 119 (6): 1638-1646. https://doi.org/10.1172/JCI36759 PMID: 19436113
37. Ercoli G, Fernandes VE, Chung YW, Wanford JJ, Thompson S, Bayliss CD, et al. Intracellular replication of Streptococcus pneumoniae inside splenic macrophages serves as a reservoir for septicaemia. Nat Microbiol. 2018; 3(5): 600-610. https://doi.org/10.1038/s41564-018-0147-1 PMID: 29662129
38. Corrales-Medina VF, Suh KN, Rose G, Chirinos JA, Doucette S, Cameron DW, et al. Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies. PLOS Med. 2011; 8(6): e1001048. https://doi.org/10.1371/journal.pmed.1001048 PMID: 21738449
39. Reyes LF, Restrepo MI, Hinojosa CA, Soni NJ, Anzueto A, Babu BL, et al. Severe pneumococcal pneumonia causes acute cardiac toxicity and subsequent cardiac remodeling. Am J Respir Crit Care Med. 2017; 196(5): 609-620. https://doi.org/10.1164/rccm.201701-0104OC PMID: 28614669
40. Surve MV, Bhutda S, Datey A, Anil A, Rawat S, Pushpakaran A, et al. Heterogeneity in pneumolysin expression governs the fate of Streptococcus pneumoniae during blood-brain barrier trafficking. PLOS Path. 2018; 14(7): e1007168. https://doi.org/10.1371/journal.ppat.1007168 PMID: 30011336